The White House is set to announce drug pricing deals with pharmaceutical companies Novartis (NVS) and Roche (RHHBY) as soon as Friday, people familiar with the situation told Bloomberg’s Rachel Cohrs Zhang and Fabienne Kinzelmann. Other drugmakers could also be included in the announcement, the report noted.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Salesforce Agentforce Life Sciences selected by Novartis
- 3 Best ETFs to Invest In, According to AI Analyst, 12/15/2025
- Novartis AG: Strong Growth Potential and Strategic Innovations Justify Buy Rating
- Novartis breaks ground on North Carolina manufacturing hub
- Novartis price target raised to $112 from $106 at HSBC